MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-50-0098602
Umang Cure Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹203.3 Cr
▲ 14% YoY
Net profit · FY 2025
₹2.25 Cr
Net margin 1.1%
EBITDA · FY 2025
₹3.27 Cr
EBITDA margin 1.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Satisfied charges
₹4.9 Cr
No open charges
Company age
30 yrs
Est. 1996
Employees · EPFO
350
Provident fund records
About Umang Cure Private Limited
Data last updated:
Umang Cure Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 03 September 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U45201DL1996PTC081645. Its GSTIN is 07AAACU1809N1Z6 (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It was formerly known as Umang Consfin Private Limited. It is led by directors Neelima Agarwal and Umang Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 213 Shanti Gopal Chamber Vikas Marg Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹203.3 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹2.25 Cr (net margin 1.1%) and EBITDA of ₹3.27 Cr (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 16% over five years.
The company has about 350 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Umang Pharmacy. As per MCA filings, the company has satisfied charges of ₹4.9 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 1 case is pending.
Umang Cure Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0098602). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website umangcure.com.
Company details
CIN U45201DL1996PTC081645
Registration Number 081645
Incorporation Date 03 September 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-50-0098602
Key People
Neelima Agarwal Director Umang Agarwal Director Recognitions & Rankings of Umang Cure
Contact details
Umang Cure Private Limited's registered office is in New Delhi, Delhi. Its website is umangcure.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 213 Shanti Gopal Chamber Vikas Marg Shakarpur, New Delhi, Delhi, India – 110092
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Umang Cure Private Limited, buy the company report.
Comprehensive company report
Umang Cure Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Umang Cure operates one associated brand: UMANG PHARMACY. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical services including medicine dispensing in Varanasi. | umangcure.com |
Business activity
The main business activity of Umang Cure is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Umang Cure Private Limited, buy the company report.
Financials of Umang Cure Private Limited
FY 2024 filings availableUmang Cure Private Limited reported revenue of ₹203.3 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹203.3 Cr ▲ 14%
Net profit · FY 2025
₹2.25 Cr margin 1.1%
EBITDA · FY 2025
₹3.27 Cr margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 27%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 22%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 14% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.25 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Umang Cure Private Limited, buy the company report.
Board of directors of Umang Cure Private Limited
Umang Cure has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelima Agarwal | Director | 18 Mar 2016 | 10 Years 7 Months | Current |
| Umang Agarwal | Director | 14 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Umang Cure Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atc Pharma Private Limited | ₹206.78 Cr (FY 2023) | -5.0% | Hyderabad, Telangana, India | |||
| Ceragem India Private Limited | ₹205.91 Cr (FY 2025) | 2.0% | Dehradun, Uttarakhand, India | |||
| Kunal Pharma Distributors Private Limited | ₹203.36 Cr (FY 2025) | 39.0% | Secunderabd, Telangana, India | |||
| Umang Cure Private Limitedthis company | ₹203.3 Cr (FY 2025) | ₹2.25 Cr | 1.1% | 14.0% | 350 | New Delhi, Delhi, India |
| Vasu Vaccines & Speciality Drugs Private Limited | ₹198.66 Cr (FY 2023) | 12.0% | Hyderabad, Telangana, India | |||
| Concept Medical Research Private Limited | ₹198.16 Cr (FY 2025) | 58.0% | Surat, Gujarat, India |
To see the full peer comparison of Umang Cure Private Limited, buy the company report.
Auditor
Umang Cure Private Limited is audited by Jainendra & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jainendra & Associates | FY 2023 | 013020N |
Shareholding
The shareholding of Umang Cure Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Umang Cure Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹4.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2016 | 100065196 | Others | ₹4.9 Cr | Satisfied |
To see the full charge records of Umang Cure Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Umang Cure Private Limited has 8 court cases on record: 7 filed by Umang Cure, 1 filed against it. 1 case is pending and 7 are disposed.
Total cases
8
Filed by the company
7
Filed against the company
1
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 1 |
| District courts | 3 | 0 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Union of India and 3 Others | Pending |
| Allahabad High Court | Court case (A227) | Filed against the company by Banaras Hindu University and 3 Others | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against Banaras Hindu University | Disposed |
| District court, Varanasi, Uttar Pradesh | Civil suit | Filed by the company against Banaras Hindu University | Disposed |
| District court, Varanasi, Uttar Pradesh | Interim or miscellaneous application | Filed by the company against Banaras Hindu University Through Vice Chancellor | Disposed |
To see the full case history of Umang Cure Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Umang Cure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Umang Cure Private Limited has a workforce of 350 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
350
Active EPFO establishments
1
Employee growth
6.71%
GST
Umang Cure has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACU1809N1Z6 | Delhi | Active | 01 Jul 2017 |
| 08AAACU1809N1Z4 | Rajasthan | Active | 01 Jul 2017 |
| 09AAACU1809N1Z2 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Umang Cure Private Limited, buy the company report.
Recent activity
Umang Cure Private Limited has 10 board changes on record since 1996: 6 appointments and 4 cessations. The latest: Alpana Agarwal ceased to be Director on 14 Jul 2023.
AGM
Umang Cure Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Umang Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Alpana Agarwal ceased to be Director.
Ceased
Shiv Charan Agarwal ceased to be Director.
Charges
A charge registered on 29 Sep 2016 via Charge ID 100065196 with Others was fully satisfied on 22 Feb 2022.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 100065196 was registered on 29 Sep 2016.
Appointed
Neelima Agarwal was appointed as Director.
Appointed
Umang Agarwal was appointed as Director.
Ceased
Nanhu Ram Agarwal ceased to be Director.
Ceased
Radha Devi ceased to be Director.
Appointed
Nanhu Ram Agarwal was appointed as Director.
Appointed
Radha Devi was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Umang Cure is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 03 September 1996 (30+ years old) and is registered under CIN U45201DL1996PTC081645.
Umang Cure has 2 current directors:
- Neelima Agarwal - Director
- Umang Agarwal - Director
The latest financial statements of Umang Cure on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Umang Cure is 07AAACU1809N1Z6, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 08AAACU1809N1Z4 (Rajasthan), 09AAACU1809N1Z2 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Umang Cure is U45201DL1996PTC081645. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Umang Cure has 8 court cases on record: 7 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Umang Cure was incorporated on 03 September 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Umang Cure by revenue are Atc Pharma Private Limited, Ceragem India Private Limited, Kunal Pharma Distributors Private Limited, Vasu Vaccines & Speciality Drugs Private Limited, Concept Medical Research Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Alpana Agarwal ceased to be Director on 14 Jul 2023. Shiv Charan Agarwal ceased to be Director on 14 Jul 2023. Neelima Agarwal was appointed as Director on 18 Mar 2016. Umang Cure has 10 board changes on record in total.
Yes, Umang Cure is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-50-0098602).
Umang Cure can be reached through the website umangcure.com. Its registered office is in New Delhi, Delhi, India.